Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,804,000 | 14,066,000 | 35,153,000 | 17,941,000 | 20,878,000 |
| Depreciation Amortization | 7,503,000 | 7,339,000 | 7,486,000 | 6,970,000 | 7,390,000 |
| Income taxes - deferred | 1,538,000 | -2,183,000 | -4,194,000 | -1,663,000 | -2,079,000 |
| Accounts receivable | -1,782,000 | -395,000 | -624,000 | -1,307,000 | -2,450,000 |
| Other Working Capital | -12,719,000 | 1,848,000 | 2,507,000 | -4,028,000 | -4,286,000 |
| Other Operating Activity | 3,186,000 | 3,591,000 | -17,537,000 | 3,281,000 | 3,957,000 |
| Operating Cash Flow | $24,530,000 | $24,266,000 | $22,791,000 | $21,194,000 | $23,410,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,112,000 | -3,749,000 | -4,185,000 | -3,466,000 | -2,941,000 |
| Net Acquisitions | -17,541,000 | -15,146,000 | N/A | -17,652,000 | -60,000 |
| Purchase Of Investment | -920,000 | -1,726,000 | -10,906,000 | -32,384,000 | -30,394,000 |
| Sale Of Investment | 1,661,000 | 2,462,000 | 19,390,000 | 41,609,000 | 25,006,000 |
| Other Investing Activity | -2,676,000 | -440,000 | -3,421,000 | -478,000 | -294,000 |
| Investing Cash Flow | $-23,588,000 | $-18,599,000 | $878,000 | $-12,371,000 | $-8,683,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,586,000 | 15,277,000 | 21,790,000 | 16,134,000 | 1,997,000 |
| Debt Issued | 9,138,000 | 6,660,000 | 0 | 2,000 | 5,000 |
| Debt Repayment | -1,757,000 | -1,453,000 | -1,551,000 | -2,134,000 | -1,802,000 |
| Common Stock Issued | 3,418,000 | 838,000 | 5,335,000 | 1,329,000 | 1,036,000 |
| Common Stock Repurchased | -5,953,000 | -2,432,000 | -5,054,000 | -6,035,000 | -3,456,000 |
| Dividend Paid | -12,381,000 | -11,823,000 | -11,770,000 | -11,682,000 | -11,032,000 |
| Other Financing Activity | -12,590,000 | -10,199,000 | -24,575,000 | -6,485,000 | -795,000 |
| Financing Cash Flow | $-5,539,000 | $-3,132,000 | $-15,825,000 | $-8,871,000 | $-14,047,000 |
| Exchange Rate Effect | 201,000 | -289,000 | -112,000 | -312,000 | -178,000 |
| Beginning Cash Position | 24,105,000 | 21,859,000 | 14,127,000 | 14,487,000 | 13,985,000 |
| End Cash Position | 19,709,000 | 24,105,000 | 21,859,000 | 14,127,000 | 14,487,000 |
| Net Cash Flow | $-4,396,000 | $2,246,000 | $7,732,000 | $-360,000 | $502,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,530,000 | 24,266,000 | 22,791,000 | 21,194,000 | 23,410,000 |
| Capital Expenditure | -4,832,000 | -4,424,000 | -4,543,000 | -4,009,000 | -3,652,000 |
| Free Cash Flow | 19,698,000 | 19,842,000 | 18,248,000 | 17,185,000 | 19,758,000 |